About Dr MICHELLE BAKER
ASc(Hons), MB BS, PhD, FRANZCO
Michelle is an Adelaide-based ophthalmologist who specialises in cataract surgery and glaucoma.
Michelle loves connecting with her patients and providing world-class evidence-based medicine tailored to each patient with the adoption of innovative technologies and her surgical skill set.
Michelle studied medicine at the University of Melbourne and undertook her early resident years as a junior doctor at Royal Melbourne Hospital. She then entered the Royal Australasian College of Surgeons training scheme and rotated through the neurosurgery, cardiothoracic, plastic surgery, maxillofacial and urology departments. Michelle acquired knowledge and skills to manage any health condition.
Michelle then changed to ophthalmology and entered the Royal Australian and New Zealand College of Ophthalmology Victorian training scheme at the Royal Victorian and Eye and Ear Hospital. Her ophthalmology training gave her an in-depth understanding of diseases affecting the eye including cataract, glaucoma, diabetes, macular degeneration and retinal vein occlusion. Following the completion of her ophthalmology training, Michelle completed medical and surgical fellowship training in glaucoma. First, at the Royal Victorian Eye and Ear Hospital and then in the United Kingdom at the Norfolk Norwich University Hospital followed by Manchester Royal Eye Hospital. This advanced surgical training equipped Michelle with further skills and subspeciality interests including angle closure disease and novel surgical techniques to manage glaucoma (cataract surgery, laser, Minimally Invasive Glaucoma Surgical techniques (MIGS), trabeculectomy surgery, Paul and Baerveldt tube implantation).
Michelle is a clinician-scientist with an interest in public health and clinical research. Concurrent with her ophthalmology training, Michelle completed a PhD on Retinal Signs in Cerebrovascular Disease at the Centre for Eye Research Australia, University of Melbourne. She has published over 18 peer-reviewed publications. Currently, Michelle is a researcher on the PROGRESSA study at Flinders University. This is a prospective study investigating how genetics and other clinical measures can be used to predict the risk of developing glaucoma in early signs of disease.
Michelle has a special interest in blindness prevention specific to indigenous eye health and developing world ophthalmology. Michelle volunteered with the National Indigenous Eye Health Survey to establish the state of Indigenous eye health in the Pilbara region of North Western Australia. Michelle was the Principal Investigator of the Solomon Islands National Ocular Trauma Audit (SINOTA) which formed the research project for her Master of Public Health. SINOTA and the subsequent publications have formed the basis for blindness prevention programs in the Western Pacific.
Michelle is a fellow of the Royal Australian and New Zealand College of Ophthalmologists and a member of the Australian and New Zealand Glaucoma Society and Australian Society of Cataract and Refractive Surgeons.
- PhD: Retinal Signs and Cerebrovascular Disease, University of Melbourne, Victoria, Australia
- MB BS, University of Melbourne, Victoria, Australia
- Assoc. Science (Hons), Capilano College, British Columbia, Canada
- Fellow, Royal Australian and New Zealand College of Ophthalmology (RANZCO)
Australian Society of Cataract and Refractive Surgeons (AUSCRS)
- Member, Australian and New Zealand Glaucoma Society (ANZGS)